Diagnosis and treatment of idiopathic hypogonadotropic hypogonadism in males.
- Author:
Luo YANG
1
;
Heng-Shan CHEN
2
;
Rui QU
1
;
Si-Xiao ZHANG
3
Author Information
1. Department of Urology and Andrology, The 4th West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
2. No.3 General Ward, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
3. Department of Urology, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
- Publication Type:Journal Article
- Keywords:
male fertility;
spermatogenic dysfunction;
treatment;
idiopathic hypogonadotropic hypogonadism
- From:
National Journal of Andrology
2018;24(8):744-747
- CountryChina
- Language:Chinese
-
Abstract:
Idiopathic hypogonadotropic hypogonadism (IHH) is often caused by hyposecretion of gonadotropin and consequently affects male fertility. The patient with IHH has a smaller penis and testes with spermatogenic dysfunction. At present, IHH is treated mainly with hCG, hMG, GnRH, and their different combinations. However, due to the lack of large-sample evidence, it is not yet clear which therapy is the best option. This article presents an overview of our experience in the treatment of IHH in the last decade and a review of relevant literature, aiming at a deeper insight into this male disease.
